PsychedelicNewsBreaks – IBN and PsychedelicNewsWire to Heighten Visibility, Widen Reach of Upcoming Psychedelic Capital Conference

IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announced that it will collaborate with Microdose Psychedelic Insights, a cutting-edge media company aiming to move the psychedelics industry to the forefront of modern medicine, for its upcoming event. The Psychedelic Capital Conference, set to be held in an entirely virtual format on Oct. 28, 2021, will feature the most innovative and cutting-edge companies, latest IPOs, newest opportunities and deepest insights into the global psychedelic industry. The event will serve to educate attendees on the potential uses and benefits attached to psychedelics in today’s environment, from exploring ongoing governmental policy shifts to commercial product breakthroughs. Together with IBN, PsychedelicNewsWire (“PNW”), in its capacity as an official media sponsor, will further the distribution of content generated for the conference to enthusiasts within the psychedelics space. “IBN, alongside its PsychedelicNewsWire brand, is pleased to be collaborating once again with Microdose Psychedelic Insights,” said Jonathan Keim, communications director for IBN. “We will leverage our communications solutions to heighten visibility in advance of the event and also widen the reach to additional investor audiences through real-time coverage.”

To view the full press release, visit https://ibn.fm/UYEiH

About Microdose Psychedelic Insights

Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, Microdose Psychedelic Insights distributes and creates the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine. For more information, visit www.Microdose.buzz.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.